Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Medpace Holdings, Inc. (MEDP) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Medpace Holdings, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1668397.
Total stock buying since 2016: $133,355,007.
Total stock sales since 2016: $3,172,605,838.
Total stock option exercises since 2016: $75,741,527.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 2 | $652 | 165,026 | $73,847,103 | 458,735 | $34,388,485 |
2024 | 0 | $0 | 1,909,367 | $767,105,506 | 141,025 | $9,955,289 |
2023 | 0 | $0 | 1,542,482 | $393,218,445 | 62,209 | $4,039,740 |
2022 | 739,926 | $112,513,478 | 97,664 | $21,596,655 | 154,900 | $10,647,741 |
2021 | 0 | $0 | 2,387,194 | $450,474,399 | 411,944 | $8,592,834 |
2020 | 0 | $0 | 2,628,886 | $329,128,348 | 238,715 | $6,472,977 |
2019 | 0 | $0 | 901,131 | $57,945,244 | 93,348 | $1,601,231 |
2018 | 0 | $0 | 17,771,543 | $880,009,538 | 0 | $0 |
2017 | 0 | $0 | 6,600,000 | $199,280,600 | 3,000 | $43,230 |
2016 | 898,776 | $20,840,877 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-07-09 | Troendle August J. (President & CEO) | Sale | 12,597 | 183.34 | 2,309,533 |
2021-07-09 | Medpace Investors, Llc | Sale | 12,597 | 183.34 | 2,309,533 |
2021-07-08 | Troendle August J. (President & CEO) | Sale | 3,951 | 180.18 | 711,891 |
2021-07-08 | Medpace Investors, Llc | Sale | 3,951 | 180.18 | 711,891 |
2021-07-07 | Troendle August J. (President & CEO) | Sale | 4,574 | 180.33 | 824,829 |
2021-07-07 | Medpace Investors, Llc | Sale | 4,574 | 180.33 | 824,829 |
2021-07-06 | Troendle August J. (President & CEO) | Sale | 4,729 | 180.58 | 853,962 |
2021-07-06 | Medpace Investors, Llc | Sale | 4,729 | 180.58 | 853,962 |
2021-07-02 | Troendle August J. (President & CEO) | Sale | 3,556 | 180.16 | 640,648 |
2021-07-02 | Medpace Investors, Llc | Sale | 3,556 | 180.16 | 640,648 |
2021-07-01 | Troendle August J. (President & CEO) | Sale | 238 | 180.03 | 42,847 |
2021-07-01 | Medpace Investors, Llc | Sale | 238 | 180.03 | 42,847 |
2021-06-28 | Troendle August J. (President & CEO) | Sale | 8,225 | 181.15 | 1,489,958 |
2021-06-28 | Medpace Investors, Llc | Sale | 8,225 | 181.15 | 1,489,958 |
2021-06-25 | Troendle August J. (President & CEO) | Sale | 10,846 | 180.56 | 1,958,353 |
2021-06-25 | Medpace Investors, Llc | Sale | 10,846 | 180.56 | 1,958,353 |
2021-06-23 | Medpace Investors, Llc | Sale | 1,837 | 180.79 | 332,111 |
2021-06-22 | Troendle August J. (President & CEO) | Sale | 12,133 | 182.31 | 2,211,967 |
2021-06-22 | Medpace Investors, Llc | Sale | 12,133 | 182.31 | 2,211,967 |
2021-06-21 | Troendle August J. (President & CEO) | Sale | 9,345 | 181.86 | 1,699,481 |
2021-06-21 | Medpace Investors, Llc | Sale | 9,345 | 181.86 | 1,699,481 |
2021-06-18 | Troendle August J. (President & CEO) | Sale | 1,261 | 180.43 | 227,522 |
2021-06-17 | Troendle August J. (President & CEO) | Sale | 8,927 | 181.20 | 1,617,572 |
2021-06-16 | Troendle August J. (President & CEO) | Sale | 17,413 | 181.13 | 3,154,016 |
2021-06-16 | Medpace Investors, Llc | Sale | 17,413 | 181.13 | 3,154,016 |
2021-06-15 | Troendle August J. (President & CEO) | Sale | 15,706 | 182.00 | 2,858,492 |
2021-06-15 | Medpace Investors, Llc | Sale | 15,706 | 182.00 | 2,858,492 |
2021-04-26 | Troendle August J. (President & CEO) | Sale | 20,729 | 193.38 | 4,008,574 |
2021-04-26 | Medpace Investors, Llc | Sale | 20,729 | 193.38 | 4,008,574 |
2021-04-23 | Troendle August J. (President & CEO) | Sale | 7,805 | 190.51 | 1,486,930 |
2021-04-23 | Medpace Investors, Llc | Sale | 7,805 | 190.51 | 1,486,930 |
2021-04-22 | Troendle August J. (President & CEO) | Sale | 14,377 | 188.64 | 2,712,077 |
2021-04-21 | Troendle August J. (President & CEO) | Sale | 15,687 | 187.02 | 2,933,782 |
2021-04-20 | Troendle August J. (President & CEO) | Sale | 17,623 | 182.44 | 3,215,140 |
2021-04-20 | Medpace Investors, Llc | Sale | 17,623 | 182.44 | 3,215,140 |
2021-04-19 | Troendle August J. (President & CEO) | Sale | 8,471 | 180.90 | 1,532,403 |
2021-04-19 | Medpace Investors, Llc | Sale | 8,471 | 180.90 | 1,532,403 |
2021-04-16 | Troendle August J. (President & CEO) | Sale | 17,528 | 180.30 | 3,160,298 |
2021-04-16 | Medpace Investors, Llc (10% Owner) | Sale | 17,528 | 180.30 | 3,160,298 |
2021-04-15 | Troendle August J. (President & CEO) | Sale | 31,270 | 186.65 | 5,836,545 |
2021-04-15 | Medpace Investors, Llc (10% Owner) | Sale | 31,270 | 186.65 | 5,836,545 |
2021-04-14 | Troendle August J. (President & CEO) | Sale | 3,720 | 180.48 | 671,385 |
2021-04-14 | Medpace Investors, Llc (10% Owner) | Sale | 3,720 | 180.48 | 671,385 |
2021-03-03 | Burwig Susan E (Exec. VP, Operations) | Sale | 6,211 | 167.00 | 1,037,237 |
2021-02-10 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 4,000 | 160.00 | 640,000 |
2021-02-10 | Geiger Jesse J (CFO & COO, Lab Operations) | Option Ex | 4,000 | 23.00 | 92,000 |
2021-02-09 | Ewald Stephen P (General Counsel & Corp. Secy.) | Sale | 10,000 | 155.48 | 1,554,800 |
2021-02-09 | Ewald Stephen P (General Counsel & Corp. Secy.) | Option Ex | 10,000 | 90.65 | 906,500 |
2021-01-08 | Troendle August J. (President & CEO) | Sale | 26,666 | 140.71 | 3,752,172 |
2021-01-08 | Medpace Investors, Llc | Sale | 26,666 | 140.71 | 3,752,172 |
2021-01-07 | Troendle August J. (President & CEO) | Sale | 93,552 | 140.06 | 13,102,893 |
2021-01-07 | Medpace Investors, Llc | Sale | 93,552 | 140.06 | 13,102,893 |
2021-01-06 | Troendle August J. (President & CEO) | Sale | 91,667 | 140.06 | 12,838,880 |
2021-01-06 | Troendle August J. (President & CEO) | Option Ex | 185,347 | 16.03 | 2,970,371 |
2021-01-06 | Medpace Investors, Llc | Sale | 91,667 | 140.06 | 12,838,880 |
2021-01-06 | Medpace Investors, Llc | Option Ex | 185,347 | 16.03 | 2,970,371 |
2021-01-04 | Troendle August J. (President & CEO) | Sale | 10,127 | 140.01 | 1,417,881 |
2021-01-04 | Medpace Investors, Llc | Sale | 10,127 | 140.01 | 1,417,881 |
2020-12-30 | Troendle August J. (President & CEO) | Sale | 19,930 | 140.01 | 2,790,399 |
2020-12-30 | Medpace Investors, Llc | Sale | 19,930 | 140.01 | 2,790,399 |
2020-12-28 | Troendle August J. (President & CEO) | Sale | 1,374 | 140.00 | 192,360 |
2020-12-28 | Medpace Investors, Llc | Sale | 1,374 | 140.00 | 192,360 |
2020-12-24 | Troendle August J. (President & CEO) | Sale | 3,829 | 140.00 | 536,060 |
2020-12-24 | Medpace Investors, Llc | Sale | 3,829 | 140.00 | 536,060 |
2020-12-23 | Troendle August J. (President & CEO) | Sale | 3,547 | 140.11 | 496,970 |
2020-12-23 | Troendle August J. (President & CEO) | Option Ex | 40,000 | 54.74 | 2,189,600 |
2020-12-23 | Medpace Investors, Llc | Sale | 3,547 | 140.11 | 496,970 |
2020-12-22 | Troendle August J. (President & CEO) | Sale | 33,260 | 140.01 | 4,656,732 |
2020-12-22 | Medpace Investors, Llc (10% Owner) | Sale | 33,260 | 140.01 | 4,656,732 |
2020-12-18 | Troendle August J. (President & CEO) | Sale | 216,048 | 141.85 | 30,646,408 |
2020-12-18 | Medpace Investors, Llc (10% Owner) | Sale | 216,048 | 141.85 | 30,646,408 |
2020-12-14 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 4,200 | 142.00 | 596,400 |
2020-12-14 | Geiger Jesse J (CFO & COO, Lab Operations) | Option Ex | 4,200 | 23.00 | 96,600 |
2020-12-10 | Ewald Stephen P (General Counsel & Corp. Secy.) | Sale | 10,000 | 140.07 | 1,400,700 |
2020-12-10 | Ewald Stephen P (General Counsel & Corp. Secy.) | Option Ex | 10,000 | 90.65 | 906,500 |
2020-12-01 | Troendle August J. (President & CEO) | Sale | 14,000 | 130.86 | 1,832,040 |
2020-12-01 | Medpace Investors, Llc | Sale | 14,000 | 130.86 | 1,832,040 |
2020-11-06 | Burwig Susan E (Exec. VP, Operations) | Option Ex | 17,037 | 14.41 | 245,503 |
2020-11-06 | Ewald Stephen P (General Counsel & Corp. Secy.) | Option Ex | 10,518 | 14.41 | 151,564 |
2020-10-08 | Burwig Susan E (Exec. VP, Operations) | Option Ex | 20,000 | 14.41 | 288,200 |
2020-10-06 | Troendle August J. (President & CEO) | Option Ex | 50,000 | 23.00 | 1,150,000 |
2020-10-05 | Troendle August J. (President & CEO) | Option Ex | 4,443 | 15.30 | 68,000 |
2020-10-05 | Medpace Investors, Llc | Option Ex | 4,443 | 15.30 | 68,000 |
2020-09-01 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 3,110 | 130.00 | 404,300 |
2020-09-01 | Geiger Jesse J (CFO & COO, Lab Operations) | Option Ex | 3,110 | 23.00 | 71,530 |
2020-08-31 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 3,700 | 130.00 | 481,000 |
2020-08-31 | Geiger Jesse J (CFO & COO, Lab Operations) | Option Ex | 3,700 | 23.00 | 85,100 |
2020-08-27 | Troendle August J. (President & CEO) | Sale | 2,034 | 121.94 | 248,025 |
2020-08-27 | Medpace Investors, Llc | Sale | 2,034 | 121.94 | 248,025 |
2020-08-26 | Troendle August J. (President & CEO) | Sale | 13,889 | 123.53 | 1,715,708 |
2020-08-26 | Medpace Investors, Llc | Sale | 13,889 | 123.53 | 1,715,708 |
2020-08-25 | Troendle August J. (President & CEO) | Sale | 11,597 | 123.23 | 1,429,098 |
2020-08-25 | Medpace Investors, Llc | Sale | 11,597 | 123.23 | 1,429,098 |
2020-08-24 | Troendle August J. (President & CEO) | Sale | 18,903 | 123.36 | 2,331,874 |
2020-08-24 | Medpace Investors, Llc | Sale | 18,903 | 123.36 | 2,331,874 |
2020-08-21 | Troendle August J. (President & CEO) | Sale | 24,304 | 124.37 | 3,022,688 |
2020-08-21 | Medpace Investors, Llc | Sale | 24,304 | 124.37 | 3,022,688 |
2020-08-20 | Troendle August J. (President & CEO) | Sale | 18,813 | 125.83 | 2,367,239 |
2020-08-20 | Medpace Investors, Llc | Sale | 18,813 | 125.83 | 2,367,239 |
2020-08-19 | Troendle August J. (President & CEO) | Sale | 21,614 | 127.63 | 2,758,594 |
2020-08-19 | Medpace Investors, Llc | Sale | 21,614 | 127.63 | 2,758,594 |
2020-08-18 | Troendle August J. (President & CEO) | Sale | 16,589 | 127.26 | 2,111,116 |
2020-08-18 | Medpace Investors, Llc | Sale | 16,589 | 127.26 | 2,111,116 |
2020-08-17 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 3,500 | 128.00 | 448,000 |
2020-08-17 | Geiger Jesse J (CFO & COO, Lab Operations) | Option Ex | 3,500 | 23.00 | 80,500 |
2020-08-17 | Troendle August J. (President & CEO) | Sale | 16,485 | 128.18 | 2,113,047 |
2020-08-17 | Medpace Investors, Llc | Sale | 16,485 | 128.18 | 2,113,047 |
2020-08-14 | Troendle August J. (President & CEO) | Sale | 16,857 | 127.07 | 2,142,018 |
2020-08-14 | Medpace Investors, Llc | Sale | 16,857 | 127.07 | 2,142,018 |
2020-08-13 | Troendle August J. (President & CEO) | Sale | 16,671 | 127.87 | 2,131,720 |
2020-08-13 | Medpace Investors, Llc | Sale | 16,671 | 127.87 | 2,131,720 |
2020-08-12 | Troendle August J. (President & CEO) | Sale | 21,916 | 127.21 | 2,787,934 |
2020-08-12 | Medpace Investors, Llc | Sale | 21,916 | 127.21 | 2,787,934 |
2020-08-11 | Troendle August J. (President & CEO) | Sale | 38,642 | 125.30 | 4,841,842 |
2020-08-11 | Medpace Investors, Llc | Sale | 38,642 | 125.30 | 4,841,842 |
2020-08-10 | Ewald Stephen P (General Counsel & Corp. Secy.) | Sale | 7,400 | 121.57 | 899,618 |
2020-08-10 | Ewald Stephen P (General Counsel & Corp. Secy.) | Option Ex | 7,400 | 23.00 | 170,200 |
2020-08-10 | Troendle August J. (President & CEO) | Sale | 48,148 | 120.79 | 5,815,796 |
2020-08-10 | Medpace Investors, Llc | Sale | 48,148 | 120.79 | 5,815,796 |
2020-08-07 | Troendle August J. (President & CEO) | Sale | 19,942 | 123.63 | 2,465,429 |
2020-08-07 | Medpace Investors, Llc | Sale | 19,942 | 123.63 | 2,465,429 |
2020-08-06 | Burwig Susan E (Exec. VP, Operations) | Sale | 7,000 | 126.00 | 882,000 |
2020-08-06 | Troendle August J. (President & CEO) | Sale | 15,033 | 122.43 | 1,840,490 |
2020-08-06 | Medpace Investors, Llc | Sale | 15,033 | 122.43 | 1,840,490 |
2020-08-05 | Troendle August J. (President & CEO) | Sale | 13,179 | 125.04 | 1,647,902 |
2020-08-05 | Medpace Investors, Llc | Sale | 13,179 | 125.04 | 1,647,902 |
2020-08-04 | Troendle August J. (President & CEO) | Sale | 45,488 | 124.43 | 5,660,071 |
2020-08-04 | Medpace Investors, Llc | Sale | 45,488 | 124.43 | 5,660,071 |
2020-08-03 | Troendle August J. (President & CEO) | Sale | 27,005 | 124.13 | 3,352,130 |
2020-08-03 | Medpace Investors, Llc | Sale | 27,005 | 124.13 | 3,352,130 |
2020-07-31 | Troendle August J. (President & CEO) | Sale | 39,622 | 118.17 | 4,682,131 |
2020-07-31 | Medpace Investors, Llc | Sale | 39,622 | 118.17 | 4,682,131 |
2020-07-30 | Burwig Susan E (Exec. VP, Operations) | Sale | 6,000 | 121.14 | 726,840 |
2020-07-30 | Troendle August J. (President & CEO) | Sale | 42,955 | 120.79 | 5,188,534 |
2020-07-30 | Medpace Investors, Llc | Sale | 42,955 | 120.79 | 5,188,534 |
2020-07-29 | Troendle August J. (President & CEO) | Sale | 47,106 | 123.99 | 5,840,672 |
2020-07-29 | Medpace Investors, Llc | Sale | 47,106 | 123.99 | 5,840,672 |
2020-07-28 | Troendle August J. (President & CEO) | Sale | 214,499 | 127.23 | 27,290,707 |
2020-07-28 | Medpace Investors, Llc | Sale | 214,499 | 127.23 | 27,290,707 |
2020-07-27 | Troendle August J. (President & CEO) | Sale | 29,019 | 110.43 | 3,204,568 |
2020-07-27 | Medpace Investors, Llc | Sale | 29,019 | 110.43 | 3,204,568 |
2020-07-24 | Troendle August J. (President & CEO) | Sale | 34,380 | 106.13 | 3,648,749 |
2020-07-24 | Medpace Investors, Llc | Sale | 34,380 | 106.13 | 3,648,749 |
2020-07-23 | Troendle August J. (President & CEO) | Sale | 31,743 | 111.83 | 3,549,819 |
2020-07-23 | Medpace Investors, Llc | Sale | 31,743 | 111.83 | 3,549,819 |
2020-07-22 | Troendle August J. (President & CEO) | Sale | 35,878 | 109.99 | 3,946,221 |
2020-07-22 | Medpace Investors, Llc | Sale | 35,878 | 109.99 | 3,946,221 |
2020-07-21 | Troendle August J. (President & CEO) | Sale | 28,090 | 106.78 | 2,999,450 |
2020-07-21 | Medpace Investors, Llc | Sale | 28,090 | 106.78 | 2,999,450 |
2020-07-20 | Troendle August J. (President & CEO) | Sale | 17,735 | 105.47 | 1,870,510 |
2020-07-20 | Medpace Investors, Llc | Sale | 17,735 | 105.47 | 1,870,510 |
2020-07-17 | Troendle August J. (President & CEO) | Sale | 19,309 | 105.32 | 2,033,623 |
2020-07-17 | Medpace Investors, Llc | Sale | 19,309 | 105.32 | 2,033,623 |
2020-07-16 | Troendle August J. (President & CEO) | Sale | 15,273 | 103.70 | 1,583,810 |
2020-07-16 | Medpace Investors, Llc | Sale | 15,273 | 103.70 | 1,583,810 |
2020-07-15 | Troendle August J. (President & CEO) | Sale | 28,700 | 104.90 | 3,010,630 |
2020-07-15 | Medpace Investors, Llc | Sale | 28,700 | 104.90 | 3,010,630 |
2020-07-13 | Troendle August J. (President & CEO) | Sale | 6,127 | 100.50 | 615,763 |
2020-07-13 | Medpace Investors, Llc | Sale | 6,127 | 100.50 | 615,763 |
2020-07-09 | Troendle August J. (President & CEO) | Sale | 2,455 | 100.15 | 245,868 |
2020-07-09 | Medpace Investors, Llc | Sale | 2,455 | 100.15 | 245,868 |
2020-05-06 | Troendle August J. (President & CEO) | Option Ex | 3,518 | 14.41 | 50,694 |
2020-05-06 | Medpace Investors, Llc (10% Owner) | Option Ex | 3,518 | 14.41 | 50,694 |
2020-01-31 | Troendle August J. (President & CEO) | Option Ex | 26,664 | 15.01 | 400,146 |
2020-01-31 | Medpace Investors, Llc | Option Ex | 26,664 | 15.01 | 400,146 |
2019-12-20 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 16,948 | 84.00 | 1,423,632 |
2019-12-19 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 14,400 | 82.00 | 1,180,800 |
2019-11-15 | Troendle August J. (President & CEO) | Option Ex | 1,073 | 15.30 | 16,422 |
2019-11-15 | Medpace Investors, Llc | Option Ex | 1,073 | 15.30 | 16,422 |
2019-10-18 | Ewald Stephen P (General Counsel & Corp. Secy.) | Sale | 8,000 | 77.30 | 618,400 |
2019-10-15 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 9,600 | 80.00 | 768,000 |
2019-10-14 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 7,200 | 78.03 | 561,816 |
2019-09-24 | Troendle August J. (President & CEO) | Option Ex | 8,386 | 15.01 | 125,848 |
2019-09-24 | Medpace Investors, Llc | Option Ex | 8,386 | 15.01 | 125,848 |
2019-05-06 | Brown Bruce | Option Ex | 18,282 | 27.77 | 507,599 |
2019-04-22 | Ewald Stephen P (General Counsel & Corp. Secy.) | Option Ex | 8,000 | 14.41 | 115,280 |
2019-04-05 | Geiger Jesse J (CFO & COO, Lab Operations) | Option Ex | 48,148 | 14.41 | 693,812 |
2019-04-01 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 25,037 | 60.00 | 1,502,220 |
2019-03-29 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 12,000 | 58.20 | 698,400 |
2019-03-29 | Ewald Stephen P (General Counsel & Corp. Secy.) | Sale | 7,946 | 57.95 | 460,470 |
2019-02-04 | Troendle August J. (President & CEO) | Sale | 18,920 | 66.54 | 1,258,936 |
2019-02-04 | Medpace Investors, Llc | Sale | 18,920 | 66.54 | 1,258,936 |
2019-02-01 | Troendle August J. (President & CEO) | Sale | 84,093 | 65.54 | 5,511,455 |
2019-02-01 | Medpace Investors, Llc | Sale | 84,093 | 65.54 | 5,511,455 |
2019-01-31 | Troendle August J. (President & CEO) | Sale | 68,383 | 64.19 | 4,389,504 |
2019-01-31 | Medpace Investors, Llc | Sale | 68,383 | 64.19 | 4,389,504 |
2019-01-30 | Troendle August J. (President & CEO) | Sale | 102,828 | 63.22 | 6,500,786 |
2019-01-30 | Medpace Investors, Llc | Sale | 102,828 | 63.22 | 6,500,786 |
2019-01-29 | Troendle August J. (President & CEO) | Sale | 1,100 | 61.05 | 67,155 |
2019-01-29 | Medpace Investors, Llc | Sale | 1,100 | 61.05 | 67,155 |
2019-01-28 | Troendle August J. (President & CEO) | Sale | 4,221 | 61.04 | 257,649 |
2019-01-28 | Medpace Investors, Llc | Sale | 4,221 | 61.04 | 257,649 |
2019-01-25 | Troendle August J. (President & CEO) | Sale | 27,958 | 61.13 | 1,709,072 |
2019-01-25 | Medpace Investors, Llc | Sale | 27,958 | 61.13 | 1,709,072 |
2019-01-24 | Troendle August J. (President & CEO) | Sale | 3,501 | 61.14 | 214,051 |
2019-01-24 | Medpace Investors, Llc | Sale | 3,501 | 61.14 | 214,051 |
2019-01-23 | Troendle August J. (President & CEO) | Sale | 24,160 | 61.22 | 1,479,075 |
2019-01-23 | Medpace Investors, Llc | Sale | 24,160 | 61.22 | 1,479,075 |
2019-01-22 | Troendle August J. (President & CEO) | Sale | 9,936 | 61.10 | 607,089 |
2019-01-22 | Medpace Investors, Llc | Sale | 9,936 | 61.10 | 607,089 |
2019-01-18 | Troendle August J. (President & CEO) | Sale | 38,318 | 61.43 | 2,353,874 |
2019-01-18 | Medpace Investors, Llc | Sale | 38,318 | 61.43 | 2,353,874 |
2019-01-17 | Troendle August J. (President & CEO) | Sale | 8,760 | 61.17 | 535,849 |
2019-01-17 | Medpace Investors, Llc | Sale | 8,760 | 61.17 | 535,849 |
2019-01-16 | Troendle August J. (President & CEO) | Sale | 7,222 | 61.57 | 444,658 |
2019-01-16 | Medpace Investors, Llc | Sale | 7,222 | 61.57 | 444,658 |
2019-01-15 | Troendle August J. (President & CEO) | Sale | 600 | 61.00 | 36,600 |
2019-01-15 | Medpace Investors, Llc | Sale | 600 | 61.00 | 36,600 |
2018-09-27 | Troendle August J. (President & CEO) | Sale | 46,778 | 58.96 | 2,758,030 |
2018-09-27 | Medpace Investors, Llc | Sale | 46,778 | 58.96 | 2,758,030 |
2018-09-26 | Troendle August J. (President & CEO) | Sale | 46,886 | 58.38 | 2,737,204 |
2018-09-26 | Medpace Investors, Llc | Sale | 46,886 | 58.38 | 2,737,204 |
2018-09-25 | Troendle August J. (President & CEO) | Sale | 38,640 | 58.36 | 2,255,030 |
2018-09-25 | Medpace Investors, Llc | Sale | 38,640 | 58.36 | 2,255,030 |
2018-09-20 | Troendle August J. (President & CEO) | Sale | 53,842 | 58.29 | 3,138,450 |
2018-09-20 | Medpace Investors, Llc (10% Owner) | Sale | 53,842 | 58.29 | 3,138,450 |
2018-09-19 | Troendle August J. (President & CEO) | Sale | 61,141 | 60.20 | 3,680,688 |
2018-09-19 | Medpace Investors, Llc (10% Owner) | Sale | 61,141 | 60.20 | 3,680,810 |
2018-08-27 | Cinven Capital Management (v) Limited Partnership Inc (10% Owner) | Sale | 5,224,997 | 54.75 | 286,068,585 |
2018-08-10 | Cinven Capital Management (v) Limited Partnership Inc (10% Owner) | Sale | 5,175,000 | 54.35 | 281,261,250 |
2018-08-07 | Troendle August J. (President & CEO) | Sale | 138,105 | 57.06 | 7,880,271 |
2018-08-06 | Troendle August J. (President & CEO) | Sale | 156,369 | 58.51 | 9,149,150 |
2018-08-03 | Troendle August J. (President & CEO) | Sale | 203,296 | 59.94 | 12,185,562 |
2018-08-02 | Geiger Jesse J (CFO & COO, Lab Operations) | Sale | 7,407 | 60.15 | 445,531 |
2018-08-02 | Troendle August J. (President & CEO) | Sale | 371,795 | 59.20 | 22,010,264 |
2018-06-14 | Cinven Capital Management (v) Limited Partnership Inc (10% Owner) | Sale | 3,000,000 | 41.80 | 125,399,999 |
2018-05-07 | Cinven Capital Management (v) Limited Partnership Inc (10% Owner) | Sale | 3,000,000 | 35.49 | 106,470,000 |
2017-12-05 | Cinven Capital Management (v) Limited Partnership Inc (10% Owner) | Sale | 4,600,000 | 30.16 | 138,740,600 |
2017-08-22 | Cinven Capital Management (v) Limited Partnership Inc (10% Owner) | Sale | 2,000,000 | 30.27 | 60,540,000 |
2017-05-02 | Bucknell Penelope J (VP, Human Resources) | Option Ex | 3,000 | 14.41 | 43,230 |
2016-08-18 | Troendle August J. (President & CEO) | Buy | 10,000 | 27.98 | 279,800 |
2016-08-17 | Burwig Susan E (Sr. Vice President, Operations) | Buy | 18,000 | 29.20 | 525,600 |
2016-08-16 | Burwig Susan E (Sr. Vice President, Operations) | Buy | 1,211 | 29.30 | 35,482 |
2016-08-16 | Troendle August J. (President & CEO) | Buy | 869,565 | 23.00 | 19,999,995 |
Insider trading activities including stock purchases, stock sales, and option exercises of MEDP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Medpace Holdings, Inc. (symbol MEDP, CIK number 1668397) see the Securities and Exchange Commission (SEC) website.